PDCD1 and cancer: This important observation, together with extensive analyses of PD-L1 on tumor cell lines (67) and tumors including HNSCC (74), raised the notion of a novel immune evasion mechanism through which cancer cells nullify anti-tumor effector T cell responses by engaging PD-1 and inducing the exhaustion phenotype (75).